Candid Health, a technology firm specializing in AI-powered revenue cycle management, has successfully closed a $120 million Series D funding round. The investment was led by Sixth Street Growth and notably triples the company's valuation from its previous financing round in early 2025. This new capital injection will fuel the expansion of its platform designed to streamline financial operations for healthcare providers across the United States.
Driving Innovation in Healthcare Finance
Candid Health's platform is engineered to automate the complex medical billing and insurance reimbursement process for healthcare organizations. Its system utilizes artificial intelligence to monitor claims continuously, validating and correcting billing data to prevent errors before they occur. This proactive approach significantly reduces administrative burdens and helps providers secure payments more efficiently and reliably.
Co-founder and CEO Nick Perry stated that legacy systems have failed to evolve with industry needs, unlike Candid's foundational approach. He emphasized that the company has spent years rebuilding the core infrastructure to deliver unprecedented cost reductions and collection increases. This strategy contrasts with competitors who merely apply a superficial layer of AI onto outdated systems.
Strategic Investment and Growth Plans
The funding round was spearheaded by global investment firm Sixth Street Growth, demonstrating strong market confidence in Candid's mission. The participation of existing investors, including Oak HC/FT, 8VC, and Y Combinator, further underscores their continued belief in the company's vision. This coalition of new and returning backers provides a robust financial foundation for the company's next phase.
With the new capital, Candid Health intends to accelerate the development and expansion of its software platform. The company will focus on growing its customer base, which currently includes over 200 healthcare organizations nationwide. A key objective is to deepen the integration between clinical and billing data to create a more seamless and automated financial system.
A Competitive and Evolving Market
This latest funding round builds upon a strong history of successful capital raises for the San Francisco-based company. Candid Health previously secured $52 million in a Series C round in 2025 and $29 million in a Series B round before that. This consistent financial momentum highlights the sustained investor interest in its innovative solution for healthcare's financial challenges.
The healthcare revenue cycle management sector is becoming increasingly competitive, attracting significant investment. For instance, rivals like Adonis recently raised $40 million in a Series C, while Commure has amassed over $750 million in total funding. This dynamic landscape underscores the urgent demand for advanced technological solutions to modernize healthcare's financial infrastructure.
This $120 million investment marks a pivotal moment for Candid Health, solidifying its position as a leader in the healthcare technology space. The funding will not only accelerate its growth but also enhance its capacity to address long-standing inefficiencies in medical billing. Ultimately, this allows healthcare providers to redirect their focus from administrative complexities to their primary mission of delivering quality patient care.